NORCURON Drug Patent Profile
✉ Email this page to a colleague
When do Norcuron patents expire, and what generic alternatives are available?
Norcuron is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in NORCURON is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norcuron
A generic version of NORCURON was approved as vecuronium bromide by MEITHEAL on August 25th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORCURON?
- What are the global sales for NORCURON?
- What is Average Wholesale Price for NORCURON?
Summary for NORCURON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Clinical Trials: | 3 |
Patent Applications: | 1,721 |
DailyMed Link: | NORCURON at DailyMed |
Recent Clinical Trials for NORCURON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The First Teaching Hospital of Xinjiang Medical University | Phase 4 |
Hebei Medical University Fourth Hospital | Phase 4 |
Shanghai Zhongshan Hospital | Phase 4 |
US Patents and Regulatory Information for NORCURON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-002 | Apr 30, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-003 | Jan 3, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NORCURON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-003 | Jan 3, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-002 | Apr 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-003 | Jan 3, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Organon Usa Inc | NORCURON | vecuronium bromide | INJECTABLE;INJECTION | 018776-002 | Apr 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NORCURON
See the table below for patents covering NORCURON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 191462 | DERIVATIVES OF 2 ,16 -BIS-PIPERIDINO-3 -HYDROXY-5 -ANDROSTANE-3 -ESTERS | ⤷ Sign Up |
Australia | 5034879 | ⤷ Sign Up | |
Australia | 526270 | ⤷ Sign Up | |
France | 1468539 | Nouveaux 2beta, 16beta-diamino-androstanes et procédé pour leur préparation | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |